BIONUMERIK PHARMACEUTICALS
BioNumerik Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drugs that help in the treatment of cancer. The company’s two oncology drug candidates, Tavocept and BNP1350, are in late-stage clinical development. BioNumerik Pharmaceuticals, Inc. was founded in 1992 and is based in San Antonio, Texas.
BIONUMERIK PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Device Pharmaceutical
Founded:
1992-01-01
Address:
San Antonio, Texas, United States
Country:
United States
Website Url:
http://www.bionumerik.com
Total Employee:
51+
Status:
Active
Contact:
210-614-1701
Email Addresses:
[email protected]
Total Funding:
63.32 M USD
Technology used in webpage:
GoDaddy DNS Person Schema Gravatar Profiles Linode
Current Employees Featured
Founder
Investors List
Takeda
Takeda investment in Corporate Round - BioNumerik Pharmaceuticals
Official Site Inspections
http://www.bionumerik.com
- Host name: 66-228-47-218.ip.linodeusercontent.com
- IP address: 66.228.47.218
- Location: Newark United States
- Latitude: 40.739
- Longitude: -74.1697
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07175
More informations about "BioNumerik Pharmaceuticals"
BioNumerik Pharmaceuticals, Inc. - LinkedIn
BioNumerik Pharmaceuticals, Inc. Pharmaceutical Manufacturing San Antonio, Texas 79 followers Developing and commercializing drugs for treating cancerSee details»
BioNumerik Pharmaceuticals - PitchBook
BioNumerik Pharmaceuticals was founded in 1992. Where is BioNumerik Pharmaceuticals headquartered? BioNumerik Pharmaceuticals is headquartered in San Antonio, TX. What …See details»
BioNumerik Pharmaceuticals, Inc. - Dun & Bradstreet
Company Description: BioNumerik Pharmaceuticals does biopharmaceutical drug development by the numbers. Using a multi-discipline process of identifying potential cancer drugs, the …See details»
Bionumerik Pharmaceuticals Inc - Company Profile and News
Company profile page for Bionumerik Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
BioNumerik Pharmaceuticals - Contacts, Employees, Board …
BioNumerik Pharmaceuticals has 1 current employee profile, Founder and CEO Frederick H. Hausheer. Frederick H. Hausheer Founder and CEO Unlock even more features with …See details»
Organization | BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Report issue For profit Phase 2 Phase 3 Founded: San Antonio TX United States (1992)See details»
BioNumerik Pharmaceuticals - Funding, Financials, Valuation
BioNumerik Pharmaceuticals is funded by Takeda. BioNumerik Pharmaceuticals has a post-money valuation in the range of $10M to $50M as of Dec 31, 2012 , according to PrivCo . Sign …See details»
BioNumerik Pharmaceuticals Inc. - BioCentury Company Profiles
Dec 17, 2019 BioNumerik Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
BioNumerik Pharmaceuticals Inc. - CareersInPharmaceutical.com
BioNumerik is a leader in a powerful new area called “mechanism-based” drug discovery, which employs multi-disciplinary science, including chemistry, biology and quantum physics, …See details»
Frederick Hausheer: Positions, Relations and Network
Apr 7, 2019 Frederick H. Hausheer founded BioNumerik Pharmaceuticals, Inc. Presently, Dr. Hausheer is Chief Medical Officer of WuXi AppTec Co., Ltd. ... American College of …See details»
Dr. Frederick H. Hausheer, MD, PhD, FACP
Dr. Frederick H. Hausheer, M.D., Ph.D., FACP, is recognized by Continental Who’s Who as a Pinnacle Professional in the field of Pharmaceuticals. Dr. Hausheer is the Founder, Chairman …See details»
BioNumerik Pharmaceuticals - Tech Stack, Apps, Patents
Nov 3, 2024 The intellectual property of BioNumerik Pharmaceuticals includes 21 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to …See details»
BioNumerik Pharmaceuticals, Inc Careers and Employment
Jan 4, 2013 Find out what works well at BioNumerik Pharmaceuticals, Inc from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. …See details»
Working at BioNumerik Pharmaceuticals - Zippia
Mar 14, 2024 38% of BioNumerik Pharmaceuticals employees are women, while 62% are men. The most common ethnicity at BioNumerik Pharmaceuticals is White (41%). 31% of …See details»
What is BioNumerik? Company Culture, Mission, Values
See what employees say it's like to work at BioNumerik. Salaries, reviews, and more - all posted by employees working at BioNumerik.See details»
Research programme: cancer therapeutics - BioNumerik …
BioNumerik Pharmaceuticals is developing several products for the treatment of cancer. BioNumerik utilises a mechanism-based approach to produce novel classesSee details»
Frederick H. Hausheer - Founder and CEO @ BioNumerik
Frederick H. Hausheer is the Founder and CEO of BioNumerik Pharmaceuticals.See details»
BioNumerik Pharmaceuticals, Inc. Commences Global Phase III
Feb 7, 2008 BioNumerik is developing Karenitecin (also known as BNP1350) as an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. Based …See details»
BioNumerik Initiates Treatment of Patients in Global Phase III …
SAN ANTONIO, Jan. 21 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the treatment of the first patients in a global multi-center Phase III clinical trial of ...See details»